AlphaYouAL
Congress trade
Rep. Alan Lowenthal (D-CA) bought $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
Alan Lowenthal, U.S. Representative (D-CA), disclosed a purchase of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Aug 13, 2017.
The trade happened on Jul 27, 2017, 17 days before it was made public.
BMY has moved +12.7% since the trade date, from $54.24 to $61.15 (Oct 2, 2026 close).
- Traded
- Jul 27, 2017
- Disclosed
- Aug 13, 2017
- Filing delay
- 17 days
- Price since
- +12.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.